Hidayet Akdemir
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hidayet Akdemir has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Hüseyin Doğu
Istanbul Atlas University
3 shared publications - Ali Osman Muçuoğlu
Department of Neurosurgery, Istanbul Atlas University Faculty of Medicine, Istanbul, Turkey
2 shared publications - Abdulkerim Gökoğlu
Department of Anatomy, Erciyes University Faculty of Medicine, Kayseri, Turkey
1 shared publication Ahmet Selçuklu
Department of Neurosurgery, Erciyes University School of Medicine, Kayseri, Turkey
1 shared publication- Anas Abdallah
Department of Neurosurgery, Istanbul Training and Research Hospital, Istanbul, Turkey
1 shared publication Aydin Paşaoğlu
Department of Neurosurgery, Erciyes University School of Medicine, Kayseri, Turkey
1 shared publication
Latest Publications
- Open Access
- 1 November 2025
- Published by Korean Neurosurgical Society in Journal of Korean Neurosurgical Society
- Vol. 68 (6) , 685-693
Familial Cerebral Cavernous Malformations : A Clinical Series and Literature Review
Objective : Familial cerebral cavernous malformation (FCCM) is a genetically inherited condition involving the collection of abnormal slow-flow venous capillaries with no cerebral parenchyma in between. In this case series, we review the clinical, radiological, pathological, and genetic findings of seven blood relatives diagnosed with FCCM and discuss their treatment in light of the different presentations.Methods : The patients with FCCMs were assessed in our neurosurgery clinic between April 2016 and October 2024. All patients underwent detailed clinical evaluation, radiological imaging, histopathological examination, and genetic testing. Functional outcomes were evaluated using the Karnofsky performance scale (KPS).Results : Five of the seven patients were symptomatic, while the remaining two were asymptomatic carriers. On radiological examination, hemorrhagic type I lesions were detected in symptomatic cases, whereas the asymptomatic carriers had non-hemorrhagic type 4 lesions. Genetic testing revealed a heterozygous pathogenic mutation in the CCM1 gene in one of the symptomatic patients. The three symptomatic cases underwent surgery for complete resection of the lesions; no additional neurological deficit or residual lesion was detected postoperatively (postoperative KPS score, 100). Histopathological examination revealed benign cavernous angioma in all cases. Over the postoperative follow-up, no seizures were detected in patients who underwent surgery due to refractory epilepsy.Conclusion : Advances in molecular genetic testing have allowed for prompt diagnosis and timely management of patients with FCCMs. Surgical treatment is an effective option in symptomatic cases with progressive neurological deficits and refractory epilepsy. Regular neurological monitoring and radiological assessment are recommended in symptomatic cases and asymptomatic carriers.
- 1 November 2025
- Published by Korean Neurosurgical Society in Journal of Korean Neurosurgical Society
- Vol. 68 (6) , 685-693
Open AccessFamilial Cerebral Cavernous Malformations : A Clinical Series and Literature Review
Objective : Familial cerebral cavernous malformation (FCCM) is a genetically inherited condition involving the collection of abnormal slow-flow venous capillaries with no cerebral parenchyma in between. In this case series, we review the clinical, radiological, pathological, and genetic findings of seven blood relatives diagnosed with FCCM and discuss their treatment in light of the different presentations.Methods : The patients with FCCMs were assessed in our neurosurgery clinic between April 2016 and October 2024. All patients underwent detailed clinical evaluation, radiological imaging, histopathological examination, and genetic testing. Functional outcomes were evaluated using the Karnofsky performance scale (KPS).Results : Five of the seven patients were symptomatic, while the remaining two were asymptomatic carriers. On radiological examination, hemorrhagic type I lesions were detected in symptomatic cases, whereas the asymptomatic carriers had non-hemorrhagic type 4 lesions. Genetic testing revealed a heterozygous pathogenic mutation in the CCM1 gene in one of the symptomatic patients. The three symptomatic cases underwent surgery for complete resection of the lesions; no additional neurological deficit or residual lesion was detected postoperatively (postoperative KPS score, 100). Histopathological examination revealed benign cavernous angioma in all cases. Over the postoperative follow-up, no seizures were detected in patients who underwent surgery due to refractory epilepsy.Conclusion : Advances in molecular genetic testing have allowed for prompt diagnosis and timely management of patients with FCCMs. Surgical treatment is an effective option in symptomatic cases with progressive neurological deficits and refractory epilepsy. Regular neurological monitoring and radiological assessment are recommended in symptomatic cases and asymptomatic carriers.
- 2 May 2025
- Published by Academician Publishing
- p. 159-184
Chiari Malformasyonları Cerrahi Tedavisinin Tarihçesi ve Güncel Yaklaşımlar
Santral sinir sisteminin kranial veya spinal kompartmanlarına bağlı nörolojik semptom ve bulguları olan Chiari malformasyonlarının (CM) tedavisinde özellikle tıbbı tedavi protokolleri yetersiz kaldığı hastalarda cerrahi tedavi seçeneklerine ihtiyaç vardır. CM’ların cerrahi tedavisinde amaç özellikle hastalığın patogenezini iyileşetirerek klinik ve radyolojik bulgu ve semptomların iyileşmesidir.Yöntemler: Tip-0, I, 1.5 CM’ların cerrahi tedavisinde minimal invazif yaklaşımlardan araknoid korumalı duraplastili posterior fossa dekompresyonu (ADPFD) tekniği çoğu Nöroşirürji kliniklerinde yaygın sıklıkla uygulanmaktadır.Sonuçlar: Chiairi malformasyonu cerrahi tedavi seçenekleri arasında minimal invazif ADPFD tekniği sonrası oluşturulan yeni yapay sisterna magnanın etrafında BOS dolanımının düzelmesiyle klinik ve radyolojik bulguların iyileşmesi tesbit edilmektedir. ADPFD minimal invazif tekniği Chiairi cerrahi tedavisinde uygulandığında kabül edilebilir postoperatif komplikasyon oranlarıyla birlikte nüks olguların mükerrer cerrahilerini de önlenmektedir. Surgical treatment options are needed for Chiari malformations (CM), which have neurological symptoms and findings related to the cranial or spinal compartments of the central nervous system, especially in patients where medical treatment protocols are insufficient. The aim of surgical treatment of CMs is to improve clinical and radiological findings and symptoms by improving the pathogenesis of the disease.Methods: Arachnoid-protected duraplasty posterior fossa decompression (ADPFD) technique, one of the minimally invasive approaches, is frequently applied in many Neurosurgery clinics in the surgical treatment of Type-0, I, 1.5 CMs.Results: It is observed that clinical and radiological findings improve with the improvement of CSF (cerebrospinal fluid) circulation around the newly created artificial cisterna magna after the minimally invasive ADPFD technique among Chiari malformation surgical treatment options. When the ADPFD minimally invasive technique is applied in Chiari surgical treatment, it also prevents repeated surgeries of recurrent cases with acceptable postoperative complication rates.
- 2 May 2025
- Published by Academician Publishing
- p. 159-184
Chiari Malformasyonları Cerrahi Tedavisinin Tarihçesi ve Güncel Yaklaşımlar
Santral sinir sisteminin kranial veya spinal kompartmanlarına bağlı nörolojik semptom ve bulguları olan Chiari malformasyonlarının (CM) tedavisinde özellikle tıbbı tedavi protokolleri yetersiz kaldığı hastalarda cerrahi tedavi seçeneklerine ihtiyaç vardır. CM’ların cerrahi tedavisinde amaç özellikle hastalığın patogenezini iyileşetirerek klinik ve radyolojik bulgu ve semptomların iyileşmesidir.Yöntemler: Tip-0, I, 1.5 CM’ların cerrahi tedavisinde minimal invazif yaklaşımlardan araknoid korumalı duraplastili posterior fossa dekompresyonu (ADPFD) tekniği çoğu Nöroşirürji kliniklerinde yaygın sıklıkla uygulanmaktadır.Sonuçlar: Chiairi malformasyonu cerrahi tedavi seçenekleri arasında minimal invazif ADPFD tekniği sonrası oluşturulan yeni yapay sisterna magnanın etrafında BOS dolanımının düzelmesiyle klinik ve radyolojik bulguların iyileşmesi tesbit edilmektedir. ADPFD minimal invazif tekniği Chiairi cerrahi tedavisinde uygulandığında kabül edilebilir postoperatif komplikasyon oranlarıyla birlikte nüks olguların mükerrer cerrahilerini de önlenmektedir. Surgical treatment options are needed for Chiari malformations (CM), which have neurological symptoms and findings related to the cranial or spinal compartments of the central nervous system, especially in patients where medical treatment protocols are insufficient. The aim of surgical treatment of CMs is to improve clinical and radiological findings and symptoms by improving the pathogenesis of the disease.Methods: Arachnoid-protected duraplasty posterior fossa decompression (ADPFD) technique, one of the minimally invasive approaches, is frequently applied in many Neurosurgery clinics in the surgical treatment of Type-0, I, 1.5 CMs.Results: It is observed that clinical and radiological findings improve with the improvement of CSF (cerebrospinal fluid) circulation around the newly created artificial cisterna magna after the minimally invasive ADPFD technique among Chiari malformation surgical treatment options. When the ADPFD minimally invasive technique is applied in Chiari surgical treatment, it also prevents repeated surgeries of recurrent cases with acceptable postoperative complication rates.
- 2 May 2025
- Published by Academician Publishing
- p. 1-14
Chiari Malformasyonu Tarihçesi, Sınıflandırmaları
Chiari malformasyonları (CM), serebellumun beyin sapının ve kraniyo-servikal birleşkenin anatomik bozukluk anomalileriyle tanımlanan, serebellumun alt kısımları birlikte orta beyinin spinal kanala doğru uzanmasıyla oluşan heterojen anomali kompleksidir. Chiairi malformasyonu hastalığı kompleksinin genellikle ergenlik ve erişkinlerde görülen alt grubları olan; Tip-0, Tip-0.5, Tip-I, Tip-1.5, Tip-3.5’lere Chairi başlığı kullanılmaktadır. Yeni doğan bebeklerde görülen Tip-2 ve Tip-3, Tip-4, Tip-5’lere ise Arnold Chiairi başlığı tercih edilmektedir. Bu heterojen kompleks anomaliye iki farklı başlık gerek Chiairi gerekse Arnold Chiairi başlıkları aynı hastalığı tanımlamak için sinonim isim olarak kullanılmaktadır. Ülkemizin sağlık SUT sisteminde bu hastalığa Arnold Chairi başlığı kullanılmaktadır. Chiari malformations (CM) are a heterogeneous anomaly complex characterized by anatomical malformation anomalies of the cerebellum, brainstem, and cranio-cervical junction, resulting in the lower parts of the cerebellum and the midbrain extending into the spinal canal.The Chiari heading is used for the subgroups of the Chiari malformation disease complex, which are generally seen in adolescence and adults; Type-0, Type-0.5, Type-I, Type-1.5, Type-3.5. The Arnold Chiari heading is preferred for Type-2, Type-3, Type-4, Type-5, which are seen in newborn babies. Two different headings, both Chiari and Arnold Chiari, are used as synonymous names to define the same disease in this heterogeneous complex anomaly. In our country's health SUT system, this disease is referred to as Arnold Chiari.
- 2 May 2025
- Published by Academician Publishing
- p. 1-14
Chiari Malformasyonu Tarihçesi, Sınıflandırmaları
Chiari malformasyonları (CM), serebellumun beyin sapının ve kraniyo-servikal birleşkenin anatomik bozukluk anomalileriyle tanımlanan, serebellumun alt kısımları birlikte orta beyinin spinal kanala doğru uzanmasıyla oluşan heterojen anomali kompleksidir. Chiairi malformasyonu hastalığı kompleksinin genellikle ergenlik ve erişkinlerde görülen alt grubları olan; Tip-0, Tip-0.5, Tip-I, Tip-1.5, Tip-3.5’lere Chairi başlığı kullanılmaktadır. Yeni doğan bebeklerde görülen Tip-2 ve Tip-3, Tip-4, Tip-5’lere ise Arnold Chiairi başlığı tercih edilmektedir. Bu heterojen kompleks anomaliye iki farklı başlık gerek Chiairi gerekse Arnold Chiairi başlıkları aynı hastalığı tanımlamak için sinonim isim olarak kullanılmaktadır. Ülkemizin sağlık SUT sisteminde bu hastalığa Arnold Chairi başlığı kullanılmaktadır. Chiari malformations (CM) are a heterogeneous anomaly complex characterized by anatomical malformation anomalies of the cerebellum, brainstem, and cranio-cervical junction, resulting in the lower parts of the cerebellum and the midbrain extending into the spinal canal.The Chiari heading is used for the subgroups of the Chiari malformation disease complex, which are generally seen in adolescence and adults; Type-0, Type-0.5, Type-I, Type-1.5, Type-3.5. The Arnold Chiari heading is preferred for Type-2, Type-3, Type-4, Type-5, which are seen in newborn babies. Two different headings, both Chiari and Arnold Chiari, are used as synonymous names to define the same disease in this heterogeneous complex anomaly. In our country's health SUT system, this disease is referred to as Arnold Chiari.
- 2 May 2025
- Published by Academician Publishing
- p. 219-240
Chiari Malformasyonu ve Siringomiyeli
Sirengomiyeli (SM) spinal kord içerisinde bir veya daha fazla spinal segment boyunca uzanan septalı, tübüler kist dolu bir boşluklara verilen isimdir. Sirengomiyeli kavitesi içerisinde epandimal hücreler bulunmamaktadır. Sirengomiyeli tanımını ilk defa 1827'de Ollivier D'Angers tarafından omurilik içerindeki kistik boşluklar için kullanmaktadır. Hidromiyeli terimi spinal kordun merkezi kanalın açık olduğu kistik genişlemesi olarak tanımlanmıştır. Hidrosirengomiyeli terimi ise sirengomiyeli ile hidromiyeli terimleri klinik veya radyolojik olarak ayırd edilemediği olgularda sinonim isim olarak kullanılmaktadır. Syringomyelia (SM) is the name given to septated, tubular cyst-filled cavities extending along one or more spinal segments within the spinal cord. There are no ependymal cells within the syringomyelia cavity. The term syringomyelia was first used by Ollivier D'Angers in 1827 for cystic cavities within the spinal cord. The term hydromyelia is defined as cystic enlargement of the central canal of the spinal cord. The term hydrosyringomyelia is used as a synonym in cases where syringomyelia and hydromyelia terms cannot be distinguished clinically or radiologically.
- 2 May 2025
- Published by Academician Publishing
- p. 219-240
Chiari Malformasyonu ve Siringomiyeli
Sirengomiyeli (SM) spinal kord içerisinde bir veya daha fazla spinal segment boyunca uzanan septalı, tübüler kist dolu bir boşluklara verilen isimdir. Sirengomiyeli kavitesi içerisinde epandimal hücreler bulunmamaktadır. Sirengomiyeli tanımını ilk defa 1827'de Ollivier D'Angers tarafından omurilik içerindeki kistik boşluklar için kullanmaktadır. Hidromiyeli terimi spinal kordun merkezi kanalın açık olduğu kistik genişlemesi olarak tanımlanmıştır. Hidrosirengomiyeli terimi ise sirengomiyeli ile hidromiyeli terimleri klinik veya radyolojik olarak ayırd edilemediği olgularda sinonim isim olarak kullanılmaktadır. Syringomyelia (SM) is the name given to septated, tubular cyst-filled cavities extending along one or more spinal segments within the spinal cord. There are no ependymal cells within the syringomyelia cavity. The term syringomyelia was first used by Ollivier D'Angers in 1827 for cystic cavities within the spinal cord. The term hydromyelia is defined as cystic enlargement of the central canal of the spinal cord. The term hydrosyringomyelia is used as a synonym in cases where syringomyelia and hydromyelia terms cannot be distinguished clinically or radiologically.
- 2 May 2025
- Published by Academician Publishing
- p. 261-278
Chiari Malformasyonu: Aile Rehberi
Chiairi malformasyonu (CM) beyinciğin alt kısımları olan serebellar tonsilleri ve/veya orta beyin sapı bölgelerini kafatasından dışarı aşağı doğru omurilik kanalına doğru sarkmasıdır. Chairi malformasyonu hastalığın tarihçesi 1880 yıllarından beri bilinmekte olup, Radyolojide günümüzün gelişmiş teknolojileri olan Magnetig Rezonans Görüntüleme (MRG) ve Bilgisayarlı Tomografi (BT) kullanımıyla kolaylıkla doğru ve hızlı teşhisi konulmaktadır. Kitabın bu bölümün amacı, hastalara ve aile üyelerine Chiari malformasyonu hastalığının doğal seyri, teşhisi ve tedavi seçenekleri konusunda tıbbi bilgileri aktarmaktır. Chiari malformasyonu teşhisi konulan hastaların hastalıkla ilgili tüm endişelerini ve sorularının cevabını tanı ve tedavi yürütecek ilgili doktorlar Nörolok, Nöroşirürjyen tarafından yanıtlanmalıdır. Ayrıca CM’li hasta ve yakınların bu hastalıkla ilgili gerek teşhisi gerekse takip ve tedavileri sürecinde nelere dikkat edilmeleri hususunu sorularına cevaplarına yer verilmektedir. Chiari malformation (CM) is the protrusion of the lower parts of the cerebellum, the cerebellar tonsils and/or the midbrain stem regions, out of the skull and down into the spinal canal. The history of Chiari malformation disease dates back to the 1880s, and with today's advanced radiology technologies such as Magnetic Resonance Imaging (MRI) and Computed Tomography (CT), it can be easily and quickly diagnosed.The purpose of this section of the book is to provide patients and family members with medical information about the natural course, diagnosis, and treatment options of Chiari malformation disease. All concerns and questions of patients diagnosed with Chiari malformation should be answered by the Neurologist and Neurosurgeon doctors who will conduct the diagnosis and treatment process. In addition, answers are provided to the questions of CM patients and their relatives regarding what they should pay attention to during the diagnosis, follow-up, and treatment processes of this disease.
- 2 May 2025
- Published by Academician Publishing
- p. 261-278
Chiari Malformasyonu: Aile Rehberi
Chiairi malformasyonu (CM) beyinciğin alt kısımları olan serebellar tonsilleri ve/veya orta beyin sapı bölgelerini kafatasından dışarı aşağı doğru omurilik kanalına doğru sarkmasıdır. Chairi malformasyonu hastalığın tarihçesi 1880 yıllarından beri bilinmekte olup, Radyolojide günümüzün gelişmiş teknolojileri olan Magnetig Rezonans Görüntüleme (MRG) ve Bilgisayarlı Tomografi (BT) kullanımıyla kolaylıkla doğru ve hızlı teşhisi konulmaktadır. Kitabın bu bölümün amacı, hastalara ve aile üyelerine Chiari malformasyonu hastalığının doğal seyri, teşhisi ve tedavi seçenekleri konusunda tıbbi bilgileri aktarmaktır. Chiari malformasyonu teşhisi konulan hastaların hastalıkla ilgili tüm endişelerini ve sorularının cevabını tanı ve tedavi yürütecek ilgili doktorlar Nörolok, Nöroşirürjyen tarafından yanıtlanmalıdır. Ayrıca CM’li hasta ve yakınların bu hastalıkla ilgili gerek teşhisi gerekse takip ve tedavileri sürecinde nelere dikkat edilmeleri hususunu sorularına cevaplarına yer verilmektedir. Chiari malformation (CM) is the protrusion of the lower parts of the cerebellum, the cerebellar tonsils and/or the midbrain stem regions, out of the skull and down into the spinal canal. The history of Chiari malformation disease dates back to the 1880s, and with today's advanced radiology technologies such as Magnetic Resonance Imaging (MRI) and Computed Tomography (CT), it can be easily and quickly diagnosed.The purpose of this section of the book is to provide patients and family members with medical information about the natural course, diagnosis, and treatment options of Chiari malformation disease. All concerns and questions of patients diagnosed with Chiari malformation should be answered by the Neurologist and Neurosurgeon doctors who will conduct the diagnosis and treatment process. In addition, answers are provided to the questions of CM patients and their relatives regarding what they should pay attention to during the diagnosis, follow-up, and treatment processes of this disease.
- 17 April 2025
- Published by Georg Thieme Verlag KG in Journal of Neurological Surgery Part A: Central European Neurosurgery
- Vol. 86 (06) , 562-573
Posterior Fossa Decompression Followed by Duraplasty with Arachnoid-Preserving Technique for Primary and Recurrent Adult Chiari Malformation Type-1.5: A Comparative Retrospective Study
Most studies on Chiari malformation (CM) are focused on CM Type-1. A new subtype, CM Type-1.5, lacks sufficient research. This study aims to evaluate the long-term surgical outcomes of posterior fossa decompression followed by duraplasty with arachnoid-preserving (PFDD-AP) technique for primary and recurrent CM Type-1.5. The medical charts of patients treated surgically for CM at our institute between January 2011 and January 2022 were reviewed retrospectively. Adult patients consecutively treated for CM Type-1.5 were selected as the core sample for the current study. Group A included primary cases (i.e., patients who had not previously been surgically treated), and Group B included recurrent cases. The surgical outcomes were compared by evaluating clinical and radiological findings. Thirty-four CM Type-1.5 cases out of 202 CM cases met the study criteria. Twenty-three and 11 cases represented Group A and Group B, respectively. The female-to-male ratio was 2/1. In Group B, the preoperative herniated tonsil extension and the obex position were statistically significantly longer, and retroversion and retroflexion angles were statistically considerably smaller ([p = 0.024; Z = − 2.26]; [p = 0.023; Z = − 2.27]; [p = 0.031; Z = − 2.29]; and [p = 0.0002; Z = − 3.72], respectively). For the cases presented with syringomyelia (SM) in both groups (n = 20), total and partial regression were recorded postoperatively in 65% and 15% of cases, respectively. The satisfactory recovery or improvement rate in neurological symptoms was 94.1%. Total or partial SM regression occurred following PFDD-AP in most adult patients with CM Type-1.5 who presented with SM. The PFDD-AP approach offers better results with fewer complications and recurrence rates. This work was carried out at the Department of Neurosurgery, Atlas University–Medicine Hospital. This comparative retrospective study was approved under decision number: (E-22686390-050.99-26421/2023) by the medical ethics committee of Atlas University, Istanbul, Turkey. * All authors contributed equally to this work and deserve the first name. Received: 06 February 2025 Accepted: 16 April 2025 Accepted Manuscript online: 17 April 2025 Article published online: 26 June 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 17 April 2025
- Published by Georg Thieme Verlag KG in Journal of Neurological Surgery Part A: Central European Neurosurgery
- Vol. 86 (06) , 562-573
Posterior Fossa Decompression Followed by Duraplasty with Arachnoid-Preserving Technique for Primary and Recurrent Adult Chiari Malformation Type-1.5: A Comparative Retrospective Study
Most studies on Chiari malformation (CM) are focused on CM Type-1. A new subtype, CM Type-1.5, lacks sufficient research. This study aims to evaluate the long-term surgical outcomes of posterior fossa decompression followed by duraplasty with arachnoid-preserving (PFDD-AP) technique for primary and recurrent CM Type-1.5. The medical charts of patients treated surgically for CM at our institute between January 2011 and January 2022 were reviewed retrospectively. Adult patients consecutively treated for CM Type-1.5 were selected as the core sample for the current study. Group A included primary cases (i.e., patients who had not previously been surgically treated), and Group B included recurrent cases. The surgical outcomes were compared by evaluating clinical and radiological findings. Thirty-four CM Type-1.5 cases out of 202 CM cases met the study criteria. Twenty-three and 11 cases represented Group A and Group B, respectively. The female-to-male ratio was 2/1. In Group B, the preoperative herniated tonsil extension and the obex position were statistically significantly longer, and retroversion and retroflexion angles were statistically considerably smaller ([p = 0.024; Z = − 2.26]; [p = 0.023; Z = − 2.27]; [p = 0.031; Z = − 2.29]; and [p = 0.0002; Z = − 3.72], respectively). For the cases presented with syringomyelia (SM) in both groups (n = 20), total and partial regression were recorded postoperatively in 65% and 15% of cases, respectively. The satisfactory recovery or improvement rate in neurological symptoms was 94.1%. Total or partial SM regression occurred following PFDD-AP in most adult patients with CM Type-1.5 who presented with SM. The PFDD-AP approach offers better results with fewer complications and recurrence rates. This work was carried out at the Department of Neurosurgery, Atlas University–Medicine Hospital. This comparative retrospective study was approved under decision number: (E-22686390-050.99-26421/2023) by the medical ethics committee of Atlas University, Istanbul, Turkey. * All authors contributed equally to this work and deserve the first name. Received: 06 February 2025 Accepted: 16 April 2025 Accepted Manuscript online: 17 April 2025 Article published online: 26 June 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 6 February 2024
- Published by Galenos Yayinevi in Journal of Turkish Spinal Surgery
- Vol. 35 (1) , 31-37
LOW-ENERGY VERTEBRAL COMPRESSION FRACTURES: DIFFERENTIAL DIAGNOSIS BETWEEN OSTEOPOROTIC AND MALIGNANT FRACTURES BY INFLAMMATORY BIOMARKERS
- 6 February 2024
- Published by Galenos Yayinevi in Journal of Turkish Spinal Surgery
- Vol. 35 (1) , 31-37
LOW-ENERGY VERTEBRAL COMPRESSION FRACTURES: DIFFERENTIAL DIAGNOSIS BETWEEN OSTEOPOROTIC AND MALIGNANT FRACTURES BY INFLAMMATORY BIOMARKERS
- 1 December 1994
- Published by Springer Nature in Neurosurgical Review
- Vol. 17 (4) , 267-273
Management of primary intracerebral hematomas
112 cases of primary intracerebral hematomas treated surgically, 25 cases aspirated with urokinase infusion and 25 cases treated conservatively in the last five years were reviewed in detail. In the craniotomy group, 17 out of 44 survivors showed good recovery and returned to normal life, 18 of them went home needing no care, 8 went home needing partial care, and one was bedridden. The overall mortality rate in this group was 59.8%. In the urokinase group, 6 out of 21 survivors showed good recovery and returned to normal life, 11 of them went home needing no care, 3 went home needing partial care and one was bedridden. The overall mortality rate in this group was 16%. In the conservative group, 8 out of 19 survivors showed good recovery and returned to normal life, 9 of them went home needing no care, and two went home needing partial care. The overall mortality rate in this group was 24%. Although the mortality rate was lower in the urokinase group compared with the conservative group, there was no statistically significant difference between the two groups (P>0.05). These results indicate that surgery is useless in deeply comatose patients and CT-guided aspiration with urokinase is a simple, effective, and safe method in appropriately selected patients.
- 1 December 1994
- Published by Springer Nature in Neurosurgical Review
- Vol. 17 (4) , 267-273
Management of primary intracerebral hematomas
112 cases of primary intracerebral hematomas treated surgically, 25 cases aspirated with urokinase infusion and 25 cases treated conservatively in the last five years were reviewed in detail. In the craniotomy group, 17 out of 44 survivors showed good recovery and returned to normal life, 18 of them went home needing no care, 8 went home needing partial care, and one was bedridden. The overall mortality rate in this group was 59.8%. In the urokinase group, 6 out of 21 survivors showed good recovery and returned to normal life, 11 of them went home needing no care, 3 went home needing partial care and one was bedridden. The overall mortality rate in this group was 16%. In the conservative group, 8 out of 19 survivors showed good recovery and returned to normal life, 9 of them went home needing no care, and two went home needing partial care. The overall mortality rate in this group was 24%. Although the mortality rate was lower in the urokinase group compared with the conservative group, there was no statistically significant difference between the two groups (P>0.05). These results indicate that surgery is useless in deeply comatose patients and CT-guided aspiration with urokinase is a simple, effective, and safe method in appropriately selected patients.